Black Diamond Therapeutics, Inc.(BDTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BDTX Black Diamond Therapeutics, Inc.

Trading 03-28 13:17:50 EDT

1.62

-0.05

-3.29%

High1.65	Low1.55	Vol760.68K
Open1.63	D1 Closing1.67	Amplitude5.99%
Mkt Cap91.51M	Tradable Cap62.96M	Total Shares56.66M
T/O1.21M	T/O Rate1.95%	Tradable Shares38.98M
P/B1.10	ROE-69.67%	EPS-1.27
52wk High7.66	52wk Low1.55	P/E-1.28
Dividend0.00	Div.Yield0.00	ROA-33.71%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BDTX","market":"US","secType":"STK","nameCN":"Black Diamond Therapeutics, Inc.","latestPrice":1.615,"timestamp":1743182246033,"preClose":1.67,"halted":0,"volume":760682,"delay":0,"floatShares":38982872,"shares":56662222,"eps":-1.266183,"marketStatus":"Trading","change":-0.055,"latestTime":"03-28 13:17:50 EDT","open":1.63,"high":1.65,"low":1.55,"amount":1208387.0201468,"amplitude":0.05988,"askPrice":1.62,"askSize":1200,"bidPrice":1.61,"bidSize":1425,"shortable":3,"etf":0,"ttmEps":-1.266183,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743192000000},"marketStatusCode":2,"adr":0,"listingDate":1580360400000,"exchange":"NASDAQ","adjPreClose":1.67,"preHourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.67,"latestTime":"09:21 EDT","volume":4509,"amount":7388.6435415,"timestamp":1743168070020},"postHourTrading":{"tag":"盘后","latestPrice":1.6403,"preClose":1.67,"latestTime":"19:56 EDT","volume":47606,"amount":78562.6833,"timestamp":1743119801123},"volumeRatio":0.306705,"impliedVol":1.2905,"impliedVolPercentile":0.416},"requestUrl":"/m/hq/s/BDTX","defaultTab":"news","newsList":[{"id":"2520437565","title":"3 Penny Stocks to Watch Now, 3/20/25","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437565?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:45","pubTimestamp":1742467547,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics, Aterian, and Biodexa Pharmaceuticals are the 3 Penny Stocks to watch on March 20, 2025, based on TipRank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-3-20-25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-3-20-25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDTX","BK4139"],"gpt_icon":0},{"id":"2520921198","title":"Sector Update: Health Care Stocks Mixed Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2520921198","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520921198?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 04:01","pubTimestamp":1742414490,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund  adding 0.1%.The iShares Biotechnology ETF  rose 0.4%.In corporate news, Black Diamond Therapeutics  shares jumped nearly 8%. The company and French pharmaceutical group Servier said Wednesday that they have signed a global licensing deal under which Servier will develop and globally commercialize BDTX-4933, a targeted therapy for solid tumors.OmniAb  shares dropped 20% after it reported a Q4 net loss late Tuesday and gave 2025 revenue guidance that missed analysts' estimates.Amarin  shareholder JEC Capital Partners and some of its affiliates urged the company's board in an open letter Wednesday to undergo a strategic review to maximize shareholder value. Amarin shares popped past 6%.HealthEquity  shares tumbled past 17% after its fiscal Q4 earnings fell short of market estimates, while it raised the top end of its full-year revenue outlook.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDTX","LU1169589451.USD","LU2065731478.USD","OABI","BK4121","LU1169590202.USD","BK4154","BK4588","BK4139","BK4585","HQY","IBB","XLV","BK4581","AMRN"],"gpt_icon":0},{"id":"2520791164","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520791164","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520791164?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 02:15","pubTimestamp":1742408120,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics  and French pharmaceutical group Servier said Wednesday that they have signed a global licensing agreement for Servier to develop and commercialize BDTX-4933, a potential targeted therapy for solid tumors.Black Diamond will receive a $70 million upfront payment and be eligible for up to $710 million in development and commercial sales milestone payments, and tiered royalties on international net sales, they said.Shares of Black Diamond soared 23% as intraday trading volume catapulted to more than 100 million shares from a daily average of about 774,000.Boeing's  Q1 cash outflow will likely be smaller than previously projected due to ongoing stabilization of factory operations and a clearing out of inventory, Chief Financial Officer Brian West said during a Bank of America conference.Shares of Boeing rose 5.5%, with trading volume of over 10 million shares against daily average of about 8.13 million.Signet Jewelers  reported a new strategy to simplify its bran","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-midday-gainers-181520101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4187","BK4551","LU1435385759.SGD","BK4588","SIG","BK4200","LU2326559502.SGD","BA","BK4516","BK4585","BDTX","LU1429558221.USD","BK4564"],"gpt_icon":1},{"id":"2520313388","title":"Black Diamond Therapeutics Shares up 36% on Licensing Deal for Tumor Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2520313388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520313388?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:31","pubTimestamp":1742391088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDTX","BK4139"],"gpt_icon":0},{"id":"2520918764","title":"BUZZ-U.S. STOCKS ON THE MOVE-Aterian, Autodesk, Ollie's","url":"https://stock-news.laohu8.com/highlight/detail?id=2520918764","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520918764?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:07","pubTimestamp":1742389624,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Aterian, Autodesk, Ollie'sEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL6N3Q20F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDY","2NVD.UK","BDTX","JILL","LU2244417387.USD","NVD3.UK","SNVD.UK","SPIR","NVDS","ETSY","CSR","SIG","ADSK","HQY","GIS","OLLI","SG9999015952.SGD","IE00BMPRXR70.SGD","ATER","BK4592","CMG","IE00B19Z9P08.USD","CG","NVIW.SI","NVD","IE00BSNM7G36.USD","LU1064131342.USD","LU2552382215.SGD","NVD2.UK","JEF","TSYW.SI","VG","LU2089284900.SGD","3NVD.UK","EPRT","NVDS.UK","TUR","GILD","LU2491050071.SGD","SGXZ51526630.SGD","LU0106831901.USD","NVDD","NVDU","MOS"],"gpt_icon":1},{"id":"2520890765","title":"Black Diamond Therapeutics Shares up 32.7% Premarket on Licensing Deal for Tumor Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2520890765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520890765?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:35","pubTimestamp":1742384154,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BDTX"],"gpt_icon":0},{"id":"2520902094","title":"BUZZ-Black Diamond rises on licensing deal for tumor treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2520902094","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520902094?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:33","pubTimestamp":1742384018,"startTime":"0","endTime":"0","summary":"BUZZ-Black Diamond rises on licensing deal for tumor treatment** Shares of precision oncology firm Black Diamond Therapeutics BDTX.O rise 35.1% to $2.26 premarket** BDTX and French drugmaker Servier say they have entered into a licensing agreement for BDTX-4933, a small molecule designed by Black Diamond ** BDTX will receive an upfront payment of $70 million and will be eligible to receive up to $710 million in development and commercial sales milestone payments, along with tiered royalties based on global net sales** Under the agreement, Servier will develop and commercialize BDTX-4933 for solid tumors including non-small cell lung cancer** BDTX-4933 is currently in early-stage development** Up to last close, BDTX has fallen 64.2% in the past 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL4N3Q20XU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139"],"gpt_icon":0},{"id":"2520902501","title":"Black Diamond, Servier announce global licensing agreement for BDTX-4933","url":"https://stock-news.laohu8.com/highlight/detail?id=2520902501","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520902501?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:10","pubTimestamp":1742382644,"startTime":"0","endTime":"0","summary":"Servier and Black Diamond Therapeutics (BDTX) announced a strategic worldwide licensing agreement for BDTX-4933, a potential best-in-class targeted...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/black-diamond-servier-announce-global-licensing-agreement-for-bdtx-4933?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/black-diamond-servier-announce-global-licensing-agreement-for-bdtx-4933?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BDTX"],"gpt_icon":0},{"id":"2520014939","title":"BRIEF-Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520014939","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520014939?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:09","pubTimestamp":1742382568,"startTime":"0","endTime":"0","summary":"BRIEF-Servier And Black Diamond Therapeutics AnnounceGlobal Licensing Agreement For BDTX-4933,A Targeted Oncology TherapyMarch 19 (Reuters) - Black Diamond Therapeutics Inc BDTX.O:SERVIER AND BLACK DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUAN5WSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139"],"gpt_icon":0},{"id":"2520909252","title":"Black Diamond Therapeutics - to Receive $70 Million Upfront, up to $710 Million in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2520909252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520909252?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUAN5WSR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BDTX"],"gpt_icon":0},{"id":"2520759909","title":"Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520759909","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520759909?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:00","pubTimestamp":1742382000,"startTime":"0","endTime":"0","summary":"The partnership underscores Servier’s commitment to developing targeted therapies that address unmet medical needs in oncology. Servier will develop and commercialize BDTX-4933, a Phase 1 asset with best-in-class potential targeting both RAS mutations and RAF alterations, in solid tumors, including non-small cell lung cancer. Black Diamond will receive an upfront payment of $70 million and up to $710million in development and commercial sales milestone payments plus royalties. Under the terms of the agreement, Servier will lead the development activities and the worldwide commercialization of BDTX-4933 across multiple indications, including non-small cell lung cancer , with potential applications in other solid tumors. Black Diamond Therapeutics will receive an upfront payment of $70million and will be eligible to receive up to $710 million in development and commercial sales milestone payments, along with tiered royalties based on global net sales.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/servier-black-diamond-therapeutics-announce-110000115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BDTX"],"gpt_icon":0},{"id":"2518246122","title":"Black Diamond Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2518246122","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518246122?lang=en_us&edition=full_marsco","pubTime":"2025-03-10 21:31","pubTimestamp":1741613501,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryBlack Diamond Therapeutics Inc BDTX.OQ reported a quarterly adjusted loss of 28 cents per share for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL8N3PT12E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX"],"gpt_icon":0},{"id":"2517490797","title":"Black Diamond Therapeutics Reports 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517490797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517490797?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 12:01","pubTimestamp":1741406487,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics, Inc. ( ($BDTX) ) has released its Q4 earnings. Here is a breakdown of the information Black Diamond Therapeutics, Inc. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/black-diamond-therapeutics-reports-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/black-diamond-therapeutics-reports-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDTX","LENZ","BK4139","BDE"],"gpt_icon":0},{"id":"2517343910","title":"Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2517343910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517343910?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 22:25","pubTimestamp":1741357552,"startTime":"0","endTime":"0","summary":"Stifel lowered the firm’s price target on Black Diamond Therapeutics (BDTX) to $15 from $16 and keeps a Buy rating on the shares. The firm updated ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/black-diamond-therapeutics-price-target-lowered-to-15-from-16-at-stifel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/black-diamond-therapeutics-price-target-lowered-to-15-from-16-at-stifel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDE","SF","BDTX","LENZ"],"gpt_icon":0},{"id":"2517098484","title":"Black Diamond Therapeutics Inc  expected to post a loss of 29 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517098484","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517098484?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 20:32","pubTimestamp":1741350764,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics Inc  expected to post a loss of29cents a share - Earnings Preview Black Diamond Therapeutics Inc BDTX.OQ BDTX.O is expected to show no change in quarterly revenue when it re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ0XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX"],"gpt_icon":0},{"id":"2517484976","title":"Black Diamond Therapeutics Inc : Wedbush Cuts Target Price to $11 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484976?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 20:27","pubTimestamp":1741350442,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BDTX"],"gpt_icon":0},{"id":"2517812414","title":"Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517812414","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517812414?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 20:13","pubTimestamp":1741349616,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics (BDTX) has an average rating of Buy and mean price target of $14.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDE","BDTX","LENZ"],"gpt_icon":0},{"id":"2517859394","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517859394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517859394?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 19:00","pubTimestamp":1741345200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Algonquin Pwr & Utl                              4Q       .09       BMO. ·Asana Inc. Class A                              4Q      (.01)  4:05 PM. ·Auna S.A. Class A                               4Q       .15       AMC. ·Vail Resorts Inc.                                2Q      6.29   4:05 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FERG","DRUG","LRMR","CVGW","CINT","ACET","SSP","FTCI","WEST","NKTR","CDTX","MGTX","CIEN","HLLY","NOA","DRRX","SFIX","ADBE","GECC","ORCL","TBRG","AUNA","ARCO","ZVRA","BBCP","LE","DKS","AMRN","EWCZ","AEO","CHRS","BNTX","ATLC","BWMN","LEN.B","LMB","AURA","CING","URGN","EVEX","ASRT","MOMO","VTS","BDTX","BTMD","BW","KRMD","KALV","MYPS"],"gpt_icon":1},{"id":"2517178210","title":"Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517178210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517178210?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 14:50","pubTimestamp":1741330213,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ventyx Biosciences (VTYX – Research Report), Black D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ventyx-biosciences-vtyx-black-diamond-therapeutics-bdtx-and-passage-bio-pasg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ventyx-biosciences-vtyx-black-diamond-therapeutics-bdtx-and-passage-bio-pasg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","PASG","BDTX","BK4139","VTYX","BK4007","HCSG"],"gpt_icon":0},{"id":"2517114958","title":"Black Diamond: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2517114958","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517114958?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 05:09","pubTimestamp":1741295355,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass.  — CAMBRIDGE, Mass.  — Black Diamond Therapeutics, Inc.  on Thursday reported a loss of $16 million in its fourth quarter.On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 28 cents.The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.For the year, the company reported that its loss narrowed to $69.7 million, or $1.27 per share.In the final minutes of trading on Thursday, the company's shares hit $1.90. A year ago, they were trading at $4.42.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/black-diamond-q4-earnings-snapshot-210915652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BDTX","BDE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackdiamondtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1117},{"period":"1month","weight":-0.1773},{"period":"3month","weight":-0.2374},{"period":"6month","weight":-0.6052},{"period":"1year","weight":-0.6592},{"period":"ytd","weight":-0.2196}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":-0.0457},{"period":"3month","weight":-0.0469},{"period":"6month","weight":-0.0077},{"period":"1year","weight":0.0839},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Black Diamond Therapeutics, Inc., a clinical-stage precision oncology medicine company, focuses on the discovery and development of therapies for patients with genetically defined cancers. The company's lead product candidate, BDTX-1535, a brain-penetrant, mutant selective, irreversible EGFR MasterKey inhibitor, designed to inhibit a family of oncogenic mutations, currently under Phase 1 clinical trial. It also develops BDTX-4933, a brain penetrant RAF MasterKey inhibitor, designed to be a brain penetrant and highly selective and potent inhibitor of oncogenic BRAF Class I, II, III and active RAF dimers, expected to initiate Phase 1 clinical trial. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.162547},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.116642},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.07382},{"month":4,"riseRate":0.6,"avgChangeRate":0.063032},{"month":5,"riseRate":0.4,"avgChangeRate":-0.11978},{"month":6,"riseRate":0.6,"avgChangeRate":0.430866},{"month":7,"riseRate":0.4,"avgChangeRate":-0.017528},{"month":8,"riseRate":0.6,"avgChangeRate":-0.018562},{"month":9,"riseRate":0.2,"avgChangeRate":-0.20342},{"month":10,"riseRate":0.4,"avgChangeRate":-0.080084},{"month":11,"riseRate":0.4,"avgChangeRate":-0.006676},{"month":12,"riseRate":0.2,"avgChangeRate":-0.057775}],"exchange":"NASDAQ","name":"Black Diamond Therapeutics, Inc.","nameEN":"Black Diamond Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Black Diamond Therapeutics, Inc.(BDTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Black Diamond Therapeutics, Inc.(BDTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Black Diamond Therapeutics, Inc.,BDTX,Black Diamond Therapeutics, Inc.股票,Black Diamond Therapeutics, Inc.股票老虎,Black Diamond Therapeutics, Inc.股票老虎国际,Black Diamond Therapeutics, Inc.行情,Black Diamond Therapeutics, Inc.股票行情,Black Diamond Therapeutics, Inc.股价,Black Diamond Therapeutics, Inc.股市,Black Diamond Therapeutics, Inc.股票价格,Black Diamond Therapeutics, Inc.股票交易,Black Diamond Therapeutics, Inc.股票购买,Black Diamond Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Black Diamond Therapeutics, Inc.(BDTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Black Diamond Therapeutics, Inc.(BDTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}